USA: The investigational siRNA therapy cemdisiran met both its primary and a key secondary endpoint in the phase III NIMBLE ...
Autism Spectrum Disorder now affects approximately 1 in 31 children in the United States, according to the CDC’s 2025 ADDM ...
It is important to recognize various disordered eating behaviors among pediatric patients with obesity, according to speakers ...
DUBAI, UNITED ARAB EMIRATES, April 4, 2026 /EINPresswire.com/ -- Mental health awareness and access to professional ...
Argenx Brings Neuromuscular Leadership To AAN 2026 With New Data Supporting Broader VYVGART Use Across MG And CIDP. <li /> ADAPT OCULUS is the first study to evaluate a targeted treatment for ocular ...
Caitlin Havener on MSN
Why is everyone suddenly obsessed with turmeric? Here's what it actually does for your body
There is something quietly fascinating happening in kitchens everywhere right now. Golden lattes are showing up on Instagram ...
The Hearty Soul on MSN
The strange phenomenon of sleep paralysis: When the body stops listening
Sleep affects nearly every system in the human body – but few sleep experiences are as disorienting, or as poorly understood, ...
Introduction Mindfulness-based interventions are widely used, yet concerns about potential negative effects—particularly those related to mindfulness meditation practice—have gained increasing ...
Kyverna is hoping to nab FDA approval for the first treatment for SPS and the first CAR T-cell therapy for an autoimmune ...
Employing in the region of 500 people, ArraTipp is an Agri dairy-based organisation formed in March 2025, from the merger of ...
The treatment landscape of generalised myasthenia gravis, a prototypic antibody-mediated disorder of the neuromuscular junction, has considerably evolved in the past 8 years.1 The approval of targeted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results